Every 8-K that Bowen Acquisition Corp (BOWN) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow BOWN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BOWN filings page.
Bowen Acquisition Corp held an extraordinary general meeting where shareholders approved an amendment allowing the board to extend the deadline to complete an initial business combination. The change was adopted by special resolution under the company’s amended and restated memorandum and articles of association.
A quorum of 2,727,780 ordinary shares was represented at the meeting. The proposal passed with 2,723,387 votes for, 4,376 against and 17 abstentions. Bowen Acquisition Corp states it is continuing to attempt to satisfy the remaining conditions to close its proposed business combination with Shenzhen Qianzhi BioTechnology Co. Ltd.
Bowen Acquisition Corp reported that its shareholders approved a charter amendment giving the board of directors authority to extend the deadline to complete an initial business combination. The change was adopted at an extraordinary general meeting held on December 12, 2025.
A total of 2,616,701 ordinary shares were represented at the meeting. The proposal passed with 2,612,224 votes in favor and 4,477 against, with no abstentions or broker non-votes. The company stated that it is continuing to attempt to satisfy the remaining conditions to close its proposed business combination with Shenzhen Qianzhi BioTechnology Co. Ltd.
Bowen Acquisition Corp. (BOWN) reported a Nasdaq delisting decision. Nasdaq notified the company on July 11, 2025 that it was not compliant with Listing Rule 5450(a)(2) requiring at least 400 total shareholders. On July 15, 2025, Nasdaq issued a delisting determination and halted trading, citing additional deficiencies, including Market Value of Listed Securities of at least $50,000,000 for 30 consecutive trading days, a minimum of 1,100,000 publicly held shares, and Market Value of Publicly Held Shares of at least $15,000,000 for 30 consecutive trading days.
After an appeal and hearing on August 21, 2025, a Panel allowed continued listing if the company completed its business combination by October 15, 2025. On October 30, 2025, Nasdaq determined to delist the securities at the open on November 3, 2025 because the combination was not completed by the deadline. Bowen has requested review by the Nasdaq Listing and Hearing Review Council; there is no assurance of continued listing or a stay.